Monitoring and evaluating efforts to control hypertension in Canada: Why, how, and what it tells us needs to be done about current care gaps

Canadian Journal of Cardiology

Volumn 29, Issue 5, 2013, Pages 564-570

  Campbell, Norm R C ^a   McAlister, Finlay A ^b   Quan, Hude ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CANADA; CARDIOVASCULAR MORTALITY; DISABILITY; DISEASE CONTROL; HEALTH BEHAVIOR; HEALTH CARE SURVEY; HEALTH PROGRAM; HYPERTENSION; PRACTICE GUIDELINE; PREVALENCE; REVIEW; SYSTOLIC BLOOD PRESSURE;

BLOOD PRESSURE MONITORING, AMBULATORY; CANADA; FEMALE; HEALTH PROMOTION; HUMANS; HYPERTENSION; MALE; PREVALENCE; PUBLIC HEALTH SURVEILLANCE;

EID: 84876804676     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2012.05.006     Document Type: Review

References (55)

1. Johansen H.L. Hypertension in Canada: risk factor review and recommendations for further work. Can J Public Health 1983, 74:123-128.
2. Chockalingam A., Campbell N., Ruddy T., Taylor G., Stewart P. Canadian national high blood pressure prevention and control strategy. Can J Cardiol 2000, 16:1087-1093. Expert Working Group.
3. Campbell N., Young E.R., Drouin D., et al. A framework for discussion on how to improve prevention, management and control of hypertension in Canada. Can J Cardiol 2012, 28:262-269.
4. Campbell N.R., Onysko J. The Outcomes Research Task Force and the Canadian Hypertension Education Program. Can J Cardiol 2006, 22:556-558.
5. McAlister F.A., Wilkins K., Joffres M., et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ 2011, 183:1007-1013.
6. Campbell N.R., Sheldon T. The Canadian effort to prevent and control hypertension: can other countries adopt Canadian strategies?. Curr Opin Cardiol 2010, 25:366-372.
7. Hemmelgarn B.R., Chen G., Walker R., et al. Trends in antihypertensive drug prescriptions and physician visits in Canada between 1996 and 2006. Can J Cardiol 2008, 24:507-512.
8. Campbell N.R.C., Tu K., Brant R., Duong-Hua M., McAlister F.A. The impact of the Canadian Hypertension Education Program on antihypertensive prescribing trends. Hypertension 2006, 47:22-28.
9. Walker R.L., Gee M.E., Bancej C., et al. Health behaviour advice from health professionals to Canadian adults with hypertension: results from a national survey. Can J Cardiol 2011, 27:446-454.
10. Walker R.L., Chen G., Campbell N.R., et al. Canadian provincial trends in antihypertensive drug prescriptions between 1996 and 2006. Can J Cardiol 2011, 27:461-467.
11. Mohan S., Chen G., Campbell N.R.C., Hemmelgarn B.R. Regional variations in not treating diagnosed hypertension in Canada. Can J Cardiol 2010, 26:409-413.
12. Bancej C.M., Campbell N., McKay D.W., Nichol M., Walker R.L., Kaczorowski J. Home blood pressure monitoring among Canadian adults with hypertension: results from the 2009 Survey on Living with Chronic Diseases in Canada. Can J Cardiol 2010, 26:e152-e157.
13. Wilkins K., Campbell N., Joffres M., et al. Blood pressure in Canadian adults. Health Rep 2010, 21:1-10.
14. McAlister F.A., Feldman R.D., Wyard K., Brant R., Campbell N.R. The impact of the CHEP in its first decade. Eur Heart J 2009, 30:1434-1439.
15. Campbell N.R., Brant R., Johansen H., et al. Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada. Hypertension 2009, 53:128-134.
16. McInnis N.H., Fodor G., Lum-Kwong M.M., Leenen F.H. Antihypertensive medication use and blood pressure control: a community-based cross-sectional survey (ON-BP). Am J Hypertens 2008, 21:1210-1215.
17. Campbell N.R., So L., Amankwah E., Quan H., Maxwell C. Characteristics of hypertensive Canadians not receiving drug therapy. Can J Cardiol 2008, 24:485-490.
18. Neutel C.I., Campbell N.R. Changes in lifestyle after hypertension diagnosis in Canada. Can J Cardiol 2008, 24:199-204.
19. Campbell N.R., McAlister F.A., Duong-Hua M., Tu K. Polytherapy with two or more antihypertensive drugs to lower blood pressure in elderly Ontarians. Room for improvement. Can J Cardiol 2007, 23:783-787.
20. Tu K., Campbell N.R.C., Chen Z., McAlister F.A. Use of beta-blockers for uncomplicated hypertension in the elderly: a cause for concern. J Hum Hypertens 2007, 21:271-275.
21. Tu K., Campbell N.R.C., Durong-Hua M., McAlister F.A. Hypertension management in the elderly has improved: Ontario prescribing trends, 1994 to 2002. Hypertension 2005, 45:1113-1118.
22. Neutel C.I., Campbell N.R.C. Antihypertensive medication use by recently diagnosed hypertensive Canadians. Can J Cardiol 2007, 23:561-565.
23. Campbell N.R.C., Onysko J., Johansen H., Gao R.-N. Changes in cardiovascular deaths and hospitalization in Canada. Can J Cardiol 2006, 22:425-427.
24. Onysko J., Maxwell C., Eliasziw M., Zhang J., Johansen H., Campbell N. Large increases in hypertension diagnosis and treatment in Canada following a health care professional education program. Hypertension 2006, 48:853-860.
25. Campbell N.R.C., McAlister F.A., Brant R., et al. Temporal trends in antihypertensive drug prescriptions in Canada before and after introduction of the Canadian Hypertension Education Program. J Hypertens 2003, 21:1591-1597.
26. Khan N., Chockalingam A., Campbell N.R.C. Lack of control of high blood pressure and treatment recommendations in Canada. Can J Cardiol 2002, 18:657-661.
27. Campbell N.R., Leiter L.A., Larochelle P., et al. Hypertension in diabetes: a call to action. Can J Cardiol 2009, 25:299-302.
28. Amankwah E., Campbell N.R.C., Maxwell C., Onysko J., Quan H. Why some adult Canadians do not have blood pressure measured. J Clin Hypertens 2007, 9:944-951.
29. Survey on Living with Chronic Diseases in Canada: Hypertension Component, 2009 Questionnaire 2009, Statistics Canada, Statistics Canada, Ottawa.
30. Gee M.E., Campbell N.R.C., Bancej C.M., et al. Perception of uncontrolled blood pressure and behaviours to improve blood pressure: findings from the 2009 Survey on Living with Chronic Diseases in Canada. J Hum Hypertens 2011, 26:188-195.
31. Tu K., Campbell N.R.C., Chen Z., Cauch-Dudek K.J., McAlister F.A. Accuracy of administrative databases in identifying patients with hypertension. Open Med 2007, 1:18-26.
32. Quan H., Khan N., Hemmelgarn B.R., et al. Validation of a case definition to define hypertension using administrative data. Hypertension 2009, 54:1423-1428.
33. Robitaille C., Dai S., Waters C., et al. Diagnosed hypertension in Canada: incidence, prevalence and associated mortality. CMAJ 2012, 184:E49-E56.
34. Report from the Canadian Chronic Disease Surveillance System: Hypertension in Canada 2010, Public Health Agency of Canada, PHAC, Ottawa.
35. IoM. A Population-Based Policy and Systems Change Approach to Prevent and Control Hypertension 2011, Committee on Public Health Priorities to Reduce and Control Hypertension in the U.S. Population, Institute of Medicine, Washington, DC.
36. Lewanczuk R. Hypertension as a chronic disease: what can be done at a regional level?. Can J Cardiol 2008, 24:483-484.
37. Kaczorowski J., Chambers L.W., Dolovich L., et al. Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP). BMJ 2011, 342:d442.
38. Jones C., Simpson S.H., Mitchell D., et al. Enhancing hypertension awareness and management in the elderly: lessons learned from the Airdrie Community Hypertension Awareness and Management Program (A-CHAMP). Can J Cardiol 2008, 24:561-567.
39. Tobe S.W., Pylypchuk G., Wentworth J., et al. Effect of nurse-directed hypertension treatment among First Nations people with existing hypertension and diabetes mellitus: the Diabetes Risk Evaluation and Microalbuminuria (DREAM 3) randomized controlled trial. CMAJ 2006, 174:1267-1271.
40. Gee M.E., Campbell N.R.C., Bancej C.M., et al. Lifestyle change for management of high blood pressure among Canadian adults with hypertension. Am J Cardiol 2012, 109:570-575.
41. Liu R., So L., Mohan S., Khan N., King K., Quan H. Cardiovascular risk factors in ethnic populations within Canada: results from national cross-sectional surveys. Open Med 2010, 4:e143-e153.
42. Gee M.E., Bienek A., McAlister F., et al. Factors associated with lack of awareness and uncontrolled high blood pressure among Canadian adults with hypertension. Can J Cardiol 2012, 28:375-382.
43. Rabi D.M., Daskalopoulou S.S., Padwal R.S., et al. The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol 2011, 27:415-433.
44. Friedman O., McAlister F., Yun L., Campbell N., Tu K. Canadian Hypertension Education Program Outcomes Research Taskforce. Antihypertensive drug persistence and compliance among newly treated elderly hypertensives in Ontario. Am J Med 2010, 123:173-182.
45. Gee M.E., Campbell N.R.C., Gwadry-Sridar F., et al. Antihypertensive medication use, adherence, stops and starts in Canadians with hypertension. Can J Cardiol 2012, 28:383-389.
46. Campbell N.R., Poirier L., Tremblay G., Lindsay P., Reid D., Tobe S.W. Canadian Hypertension Education Program: the science supporting new 2011 CHEP recommendations with an emphasis on health advocacy and knowledge translation. Can J Cardiol 2011, 27:407-414.
47. Global Risks 2009 - A Global Risk Network Report 2009, Global Risk Network of the World Economic Forum, World Economic Forum, Cologny/Geneva, Switzerland.
48. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks 2009, World Health Organization, World Health Organization, Geneva, Switzerland.
49. Klarenbach S.W., McAlister F.A., Johansen H., et al. Identification of factors driving differences in cost effectiveness of first-line pharmacological therapy for uncomplicated hypertension. Can J Cardiol 2010, 26:e158-e163.
50. Heidenreich P.A., Trogdon J.G., Khavjou M.A., et al. AHA policy statement: forecasting the future of cardiovasular disease in the United States. Circulation 2011, 123:933-944.
51. Gaziano T.A., Bitton A., Anand S., Weinstein M.C. The global cost of nonoptimal blood pressure. J Hypertens 2009, 27:1472-1477.
52. First Nations Regional Longitudinal Health Survey (RHS) 2002/03-Results for Adults, Youth and Children living in First Nations Communities 2005, 52-60. Assembly of First Nations, First Nations Centre, Ottawa, Ontario.
53. Montague T.J., Gogovor A., Krelenbaum M. Time for chronic disease care and management. Can J Cardiol 2007, 23:971-975.
54. Goff D.C., Brass L., Braun L.T., et al. Essential features of a surveillance system to support the prevention and management of heart disease and stroke. A scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Stroke, and Cardiovascular Nursing and the Interdisciplinary Working Groups on Quality of Care and Outcomes Research and Atherosclerotic Peripheral Disease. Circulation 2007, 115:127-155.
55. Tobe S.W., Stone J.A., Brouwers M., et al. Harmonization of guidelines for the prevention and treatment of cardiovascular disease: the C-CHANGE Initiative. CMAJ 2011, 183:E1135-E1150.